SMAD2 and cancer: Since it has been demonstrated that Smad2/3 and E2F1 are critical mediators of TGF-β-induced EMT in both normal and cancer cells (18), we examined the effects of TGF-β1 and miR-20b-5p on Smad2 phosphorylation and E2F1 expression.